Vir Biotechnology logo

Vir Biotechnology Share Price Today

(NASDAQ: VIR)

Vir Biotechnology share price is $8.22 & ₹714.89 as on 6 Mar 2025, 2.30 'hrs' IST

$8.22

0.02

(0.24%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Vir Biotechnology share price in Dollar and Rupees. Guide to invest in Vir Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vir Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Vir Biotechnology share price movements

  • Today's Low: $8.12
    Today's High: $8.51

    Day's Volatility :4.64%

  • 52 Weeks Low: $6.56
    52 Weeks High: $14.45

    52 Weeks Volatility :54.6%

Vir Biotechnology (VIR) Returns

PeriodVir Biotechnology IncSector (Health Care)Index (Russel 2000)
3 Months
2.89%
2.1%
0.0%
6 Months
7.19%
-4.1%
0.0%
1 Year
-24.91%
2.2%
0.0%
3 Years
-63.51%
11.8%
-11.6%

Vir Biotechnology (VIR) Key Statistics

in dollars & INR

Previous Close
$8.2
Open
$8.26
Today's High
$8.51
Today's Low
$8.115
Market Capitalization
$1.1B
Today's Volume
$663.4K
52 Week High
$14.45
52 Week Low
$6.56
Revenue TTM
$74.2M
EBITDA
$-508.9M
Earnings Per Share (EPS)
$-3.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.59%
Return On Equity TTM
-38.09%

How to invest in Vir Biotechnology Stock (VIR) from India?

It is very easy for Indian residents to invest directly in Vir Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vir Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vir Biotechnology or VIR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vir Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vir Biotechnology shares which would translate to 0.106 fractional shares of Vir Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vir Biotechnology, in just a few clicks!

Returns in Vir Biotechnology (VIR) for Indian investors in Rupees

The Vir Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vir Biotechnology investment value today

Current value as on today

₹80,237

Returns

₹19,763

(-19.76%)

Returns from Vir Biotechnology Stock

₹24,725 (-24.73%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Vir Biotechnology (VIR)

-39%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Vir Biotechnology Stock from India on INDmoney has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vir Biotechnology

  • SB INVESTMENT ADVISERS (UK) LTD

    12.17%

  • BlackRock Inc

    12.00%

  • Vanguard Group Inc

    9.57%

  • State Street Corp

    3.70%

  • Orbimed Advisors, LLC

    2.35%

  • Geode Capital Management, LLC

    1.60%

Analyst Recommendation on Vir Biotechnology

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Vir Biotechnology(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Vir Biotechnology Stock (VIR)

What analysts predicted

Upside of 289.29%

Target:

$32.00

Current:

$8.22

Insights on Vir Biotechnology Stock (Ticker Symbol: VIR)

  • Price Movement

    In the last 7 days, VIR stock has moved down by -10.9%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.38M → 11.27M (in $), with an average increase of 78.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -213.71M → -104.58M (in $), with an average increase of 104.3% per quarter
  • VIR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 86.9%
  • VIR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 112.4%
  • Price to Sales

    ForVIR every $1 of sales, investors are willing to pay $15.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Vir Biotechnology Technicals Summary

Sell

Neutral

Buy

Vir Biotechnology is currently in a neutral trading position according to technical analysis indicators.

Vir Biotechnology (VIR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vir Biotechnology Inc logo
-17.84%
7.19%
-24.91%
-63.51%
-78.97%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vir Biotechnology Inc logo
6.4
NA
NA
-3.37
-0.38
-0.2
NA
8.4
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vir Biotechnology Inc logo
Buy
$1.1B
-78.97%
6.4
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Vir Biotechnology

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.
Organization
Vir Biotechnology
Employees
408
CEO
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Industry
Commercial Services

Management People of Vir Biotechnology

NameTitle
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
CEO & Director
Dr. Ann M. Hanly Ph.D.
Executive VP & Chief Technology Officer
Dr. Jeff Calcagno M.D.
Executive VP & Chief Business Officer
Dr. Lawrence Corey M.D.
Co-Founder & Scientific Advisor
Dr. Louis J. Picker M.D.
Co-Founder & Scientific Advisor
Mr. Jason O'Byrne
Executive VP & CFO
Mr. Brent Sabatini
Senior VP, Principal Accounting Officer & Chief Accounting Officer
Dr. Jennifer Eileen Towne Ph.D.
Executive VP & Chief Scientific Officer
Ms. Vanina de Verneuil J.D.
Executive VP, General Counsel & Corporate Secretary
Ms. Arran Attridge
Senior Vice President of Corporate Communications

Important FAQs about investing in VIR Stock from India :

What is Vir Biotechnology share price today?

Vir Biotechnology share price today stands at $8.22, Open: $8.26 ; Previous Close: $8.20 ; High: $8.51 ; Low: $8.12 ; 52 Week High: $14.45 ; 52 Week Low: $6.56.

The stock opens at $8.26, after a previous close of $8.20. The stock reached a daily high of $8.51 and a low of $8.12, with a 52-week high of $14.45 and a 52-week low of $6.56.

Can Indians buy Vir Biotechnology shares?

Yes, Indians can invest in the Vir Biotechnology (VIR) from India.

With INDmoney, you can buy Vir Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vir Biotechnology at zero transaction cost.

How can I buy Vir Biotechnology shares from India?

It is very easy to buy Vir Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vir Biotechnology (VIR) be purchased?

Yes, you can buy fractional shares of Vir Biotechnology with INDmoney app.

What are the documents required to start investing in Vir Biotechnology stocks?

To start investing in Vir Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vir Biotechnology Stock (VIR)?

Today’s highest price of Vir Biotechnology (VIR) is $8.51.

Today’s lowest price of Vir Biotechnology (VIR) is $8.12.

What is today's market capitalisation of Vir Biotechnology?

Today's market capitalisation of Vir Biotechnology VIR is 1.1B

What is the 52 Week High and Low Range of Vir Biotechnology Stock (VIR)?

  • 52 Week High

    $14.45

  • 52 Week Low

    $6.56

What are the historical returns of Vir Biotechnology (VIR)?

  • 1 Month Returns

    -17.84%

  • 3 Months Returns

    7.19%

  • 1 Year Returns

    -24.91%

  • 5 Years Returns

    -78.97%

Who is the Chief Executive Officer (CEO) of Vir Biotechnology ?

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. is the current Chief Executive Officer (CEO) of Vir Biotechnology.